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Hematopoietic stem cells (HSCs) emerge from 
the major arterial vessels during embryonic de-
velopment. Embryonic vascular development 
is closely associated with HSC generation be-
cause arteries provide the niche HSC generation 
and both lineages share a common endothelial 
progenitor (Zovein et al., 2008; Chen et al., 
2009). The process by which an HSC precur-
sor with endothelial characteristic acquires the 
hematopoietic identity is known as endothelial 
to hematopoietic transition. HSCs develop within 
specific cell clusters budding from the endo-
thelium to the lumen of the dorsal aorta in the 
region comprised between the junctions of the 
vitellin and umbilical arteries (Yokomizo and 
Dzierzak, 2010). These hematopoietic clusters 
CORRESPONDENCE  
Anna Bigas:  
abigas@imim.es
Abbreviations used: AGM, 
aorta-gonad-mesonephros; ChIP, 
chromatin immunoprecipi-
tation; CHT, caudal hema-
topoietic tissue; EB, embryoid 
body; EMP, erythroid/myeloid 
progenitor; ESC, embryonic 
stem cell; HEP, hematoendo-
thelial precursor; hpf, hour 
postfertilization; HSC, hemato-
poietic stem cell; ISH, in situ 
hybridization; MO, morpholino 
oligo; SCF, stem cell factor; 
TSS, transcriptional start site.
*L. Espinosa and A. Bigas contributed equally to this paper.
D.J.M. Bergen’s present address is Cell Biology Laboratories, 
School of Biochemistry, University of Bristol, Bristol BS8 
1TD, England, UK.
E. Dzierzak’s present address is The Queen’s Medical Research 
Institute, College of Medicine and Veterinary Medicine, The 
University of Edinburgh, Edinburgh EH16 4TJ, Scotland, UK.
Identification of Cdca7 as a novel  
Notch transcriptional target involved  
in hematopoietic stem cell emergence
Jordi Guiu,1 Dylan J.M. Bergen,1 Emma De Pater,2 Abul B.M.M.K. Islam,3,4 
Verónica Ayllón,5 Leonor Gama-Norton,1 Cristina Ruiz-Herguido,1  
Jessica González,1 Nuria López-Bigas,3,7 Pablo Menendez,6,7  
Elaine Dzierzak,2 Lluis Espinosa,1* and Anna Bigas1*
1Program de Recerca en Càncer, Institut Hospital del Mar d’Investigacions Mèdiques, Parc de Recerca Biomèdica de Barcelona, 
08003 Barcelona, Spain
2Erasmus MC Stem Cell and Regenerative Medicine Institute, Erasmus Medical Center, 3000 CA Rotterdam, Netherlands
3Research Unit on Biomedical Informatics, Department of Experimental and Health Sciences, Pompeu Fabra University,  
08003 Barcelona, Spain
4Department of Genetic Engineering and Biotechnology, University of Dhaka, Dhaka 1000, Bangladesh
5Centre for Genomics and Oncological Research (Genyo), Pfizer–University of Granada–Andalusian Government,  
18016 Granada, Spain
6José Carreras Leukaemia Research Institute, Cell Therapy Program, School of Medicine, University of Barcelona,  
08036 Barcelona, Spain
7Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain
Hematopoietic stem cell (HSC) specification occurs in the embryonic aorta and requires 
Notch activation; however, most of the Notch-regulated elements controlling de novo HSC 
generation are still unknown. Here, we identify putative direct Notch targets in the  
aorta-gonad-mesonephros (AGM) embryonic tissue by chromatin precipitation using anti-
bodies against the Notch partner RBPj. By ChIP-on-chip analysis of the precipitated DNA, 
we identified 70 promoter regions that were candidates to be regulated by Notch in the 
AGM. One of the most enriched regions corresponded to the Cdca7 gene, which was subse-
quently confirmed to recruit the RBPj factor but also Notch in AGM cells. We found that 
during embryonic hematopoietic development, expression of Cdca7 is restricted to the 
hematopoietic clusters of the aorta, and it is strongly up-regulated in the hemogenic 
population during human embryonic stem cell hematopoietic differentiation in a Notch-
dependent manner. Down-regulation of Cdca7 mRNA in cultured AGM cells significantly 
induces hematopoietic differentiation and loss of the progenitor population. Finally, using 
loss-of-function experiments in zebrafish, we demonstrate that CDCA7 contributes to HSC 
emergence in vivo during embryonic development. Thus, our study identifies Cdca7 as an 
evolutionary conserved Notch target involved in HSC emergence.
© 2014 Guiu et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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induction of Cdca7 expression is recapitulated during early 
hematopoietic differentiation of human embryonic stem cells 
(ESCs [hESCs]), whereas down-regulation of Cdca7 in the 
AGM cells induces a rapid differentiation of hematopoietic 
progenitors. In the zebrafish embryo, knocking down Cdca7 
significantly reduced HSC generation in vivo.
RESULTS
Screening for novel Notch/RBPj transcriptional  
targets in the AGM region
We performed chromatin immunoprecipitation (ChIP)– 
on-chip analysis with anti-RBPj antibodies using cross-linked 
chromatin from embryonic day (E) 11.5 dissected AGMs 
(scheme in Fig. 1 A). A set of putative targets was obtained 
with a stringent analysis by combining three bioinformatic 
tools (iChip1, iChip2, and Chipper; Fig. 1 B). Compared with 
the whole set of probes represented in the array (includes 
from 5 to 2.5 kb from the transcriptional start sites [TSSs]), 
RBPj-bound regions showed enrichment in the proximal pro-
moters, including the TSSs (Fig. 1 C). When overlapping the 
putative RBPj/Notch targets from the three independent 
analyses, 701 promoter regions showed enriched RBPj recruit-
ment relative to the input, of which 676 (675 genes and 
1 miRNA) were annotated with an Ensembl gene ID (Fig. 1 B 
and Table S1). Our list of RBP-binding genes included two 
Hey/Hes family members, as well as other previously identi-
fied Notch targets such as Bcl-2, NRARP, PTEN, and Deltex2 
(Table S1). Precipitation with an irrelevant Ig confirmed the 
specificity of the experiment (not depicted). In silico analysis 
of the promoter regions of identified genes showed a strong 
enrichment of RBPj motifs in the 1-kb region from their 
TSS sequence (Fig. 1 D). To investigate the possibility that 
Notch/RBPj-regulated genes in the AGM were clustered 
into specific functions or signaling pathways, Gene Ontology 
(GO) analysis (GO gene function and GO KEGG pathways) 
was performed. We found that genes identified as RBPj tar-
gets associated with DNA/chromatin regulation, cell division, 
and stem cell division. Remarkably, genes associated to the 
Wnt and Notch pathways were also significantly enriched in 
the group of RBPj targets (Fig. 1 E). By literature mining, we 
found that several of the identified genes played a recognized 
function in embryonic development, cancer, and/or hemato-
poiesis (Fig. 1 F). These genes include the transcription factors 
SRY-related HMG-box-4 (Sox4) and homeobox A1 (HoxA1), 
the cell cycle regulator Cdca7, the Notch receptor modulator 
Ktelc1 (Rumi), the Delta ubiquitin ligase Mindbomb2 (Mib2), 
and the canonical Notch targets Hes1 and Hey1.
We further validated our ChIP-on-chip results by quan-
titative PCR (qPCR) analysis on an independent RBPj pre-
cipitation using primers around the enriched peaks of six 
randomly selected target genes. Analysis of the WAS protein 
family member 1 (Wasf1), Epithelial cell transforming sequences 2 
oncogene (Ect2), Cdca7, Hes1, using the 28S ribosomal RNA 
(R28S) as a negative control, confirmed the enrichment de-
tected by ChIP-on-chip (Fig. 1 G). In contrast, the genes Fbx19, 
Gna12, and Gnai, which were also identified in the initial 
contain a variety of cells that express different cell surface mark-
ers such as c-kit or CD41 or CD45 and include those that will 
acquire the stemness capacity. After release into circulation, 
these cells are amplified in the fetal liver, giving rise to the 
adult HSCs.
The process of HSC generation requires the orchestration 
of crucial developmental pathways, including Notch and Wnt 
(Robert-Moreno et al., 2005; Ruiz-Herguido et al., 2012). 
Notch signaling regulates cell fate decisions with a central role 
in vascular and hematopoietic development (Bigas and Espinosa, 
2012). Notch activity is first required to generate arteries, and 
Notch inhibition favors vein formation from the prepatterned 
endothelial network (You et al., 2005). Activation of Notch 
can be achieved by its interaction with either Delta or Jagged 
ligands, thus triggering the proteolytic cleavage and release of 
the active Notch intracellular fragment (ICN) that will induce 
a transcriptional response together with its nuclear partners 
RBPj and Mastermind (Mam). However, Notch activation 
during arterial determination specifically depends on the 
Delta4 ligand (Duarte et al., 2004; Krebs et al., 2004), whereas 
HSC generation in the hematopoietic clusters of the aorta-
gonad-mesonephros (AGM) is mostly dependent on Jagged1 
(Robert-Moreno et al., 2008). Thus, Jagged1-deficient em-
bryos provide a unique system to study the role of Notch in 
embryonic hematopoiesis in a normal arterial scenario. This 
specific Notch function is not restricted to mammals, as it 
also regulates zebrafish (Burns et al., 2005) as well as Drosophila 
melanogaster hematopoietic development (Mandal et al., 2004; 
Terriente-Felix et al., 2013). In the mouse, only two direct 
Notch targets involved in HSC generation have been identi-
fied, but it is expected that other genes that participate in this 
process will also depend on Notch, as it has been shown in 
Drosophila (Terriente-Felix et al., 2013). In particular, Notch1 
receptor signaling induces the activation of an incoherent 
feed-forward loop involving the Hairy and enhancer of split 1 
(Hes1) repressor and the Gata2 transcription factor, which 
results in fine tuning of Gata2 levels and is essential to gener-
ate functional HSCs (Guiu et al., 2013). Similar regulatory 
loops for other Notch-dependent genes have been identified 
in Drosophila (Krejcí and Bray, 2007), which indicates the 
conservation of a mechanism that modulates context-specific 
targets through general Notch effectors such as Hes repressors. 
Genes regulated by these feed-forward regulatory loops are 
hard to identify in most of the screenings because once Notch 
is artificially stimulated or repressed, both the activating and 
the repressing complexes are simultaneously modified.
To identify novel HSC regulators that are targets of Notch 
in the AGM, we have based our strategy on (a) the identifica-
tion of gene promoters that bind RBPj, (b) the selection of 
candidate genes by the presence of RBP binding consensus, 
and (c) the analysis of the expression patterns in the AGM of 
WT and Jag1 mutant embryos. Following this strategy, we 
identified Cell division cycle associated 7 (Cdca7) as a Notch/
RBPj target gene that is activated in the HSC precursors in 
the mouse embryo and maintained thereafter in distinct un-
differentiated hematopoietic populations. Notch-dependent 
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Figure . ChIP-on-chip analysis of E.5 AGMs. (A) Schematic representation of the ChIP-on-chip procedure. (B) 701 overlapping promoter regions 
(red with blue stripes) between iChip (blue circle) and Chipper (red circle) software were identified. (C) Comparing the relative probe enrichment of identi-
fied RBPj targets by Chipper and iChip to all probes. (D) RBPj-binding motif scanning (TGGGAAANT) in a range of 1 to 2 kb from the TSS showed signifi-
cantly more binding sites in the 675 promoter regions with an Ensembl ID than all of the promoter regions (*, P = 0.021; 2 = 5.259). (E) GO biological 
process (GO-BP) and pathway (KEGG) analysis in the 676 overlapping group. (F) Selection of putative RBPj targets showing the gene symbol, hit number, 
and enrichment p-value. (G) qPCR analysis for RBPj recruitment to the selected genes in an independent ChIP from E11.5 AGMs (n = 3). (H) Recruitment 
of ICN1 to the selected genes, assessed by ChIP from E11.5 AGMs (n = 3). (I) qRT-PCR analysis on cDNA of E10.5 dissected AGMs from Jag1+/+ and 
Jag1/ embryos from confirmed ICN1 and RBPj target genes (Ect2, Wasf1, and Hes1); Gata2 and Dll4 are shown as controls (n = 4). (J) A pool of six 
E10.5 AGMs from Jag1/ was disrupted with collagenase and cultured. In this culture ICN1-IRES-GFP was transduced, and after 1 wk, infected cells (GFP+) 
were sorted and the indicated genes were analyzed by qRT-PCR (n = 3). Error bars represent the SD.
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activation or inactivation in HEK-293T cells. Simultaneous 
expression of the ICN1 construct (N1E) and Mam signifi-
cantly increased the activity of the Cdca7 promoter compared 
with the control or with ICN1 construct alone (Fig. 2 E). 
Conversely, inhibition of Notch activity by DAPT or by trans-
fection of a dominant-negative form of RBPj resulted in a sig-
nificant reduction in the activity of the promoter (Fig. 2 E). 
Furthermore, we found that mutation of both adjacent RBP-
binding sites totally abolished the Notch-dependent activation 
of the construct (Fig. 2 F), whereas single mutations of the 
distal site (260) did not significantly affect its activity. Alto-
gether, these results indicate that a Notch complex containing 
RBPj, Notch1, and Mam directly regulates the transcriptional 
activation of Cdca7. However, in vitro activation of the proxi-
mal promoter does not require Notch homodimerization.
Cdca7 is expressed in the aortic clusters and hemogenic 
precursors from AGM and hESCs
We next investigated the putative role of CDCA7 during 
development of the murine hematopoietic system. By in situ 
hybridization (ISH) of midgestation embryos, we found that 
Cdca7 was mainly expressed in the hematopoietic cluster–like 
structures in the AGM, which contain the newly formed HSCs, 
but also in the fetal liver (Fig. 3 A). In contrast, Cdca7 was not 
detected in the rest of the aortic endothelial cells, suggesting 
that Cdca7 is involved in hematopoietic emergence but not 
in arterial specification (Fig. 3 A). Similar results were obtained 
by immunostaining of the CDCA7 protein (Fig. 3 B). As ex-
pected, ISH analysis showed that Cdca7 expression was com-
pletely abolished in the aorta of Jag1/ embryos (Fig. 3 C), in 
agreement with the qRT-PCR results (Fig. 1 I).
To study whether Cdca7 is differentially expressed in specific 
HSC populations, we took advantage of gene expression data 
available in public databases (GEO accession nos. GSE37000 
and GSE27787). These experiments include data of purified 
HSCs obtained from E11.5 AGM (VEC+CD45+), E12.5 FL 
(LSK), and LT-HSCs from adult BM (CD150+CD48LSK; 
McKinney-Freeman et al., 2012) and different subpopula-
tions of hematopoietic progenitors and mature cells (Konuma 
et al., 2011). Interestingly, Cdca7 mRNA is highly expressed 
in HSCs from all different developmental stages (Fig. 3 D), 
and its expression is lower in differentiated cells from spe-
cific hematopoietic lineages (Fig. 3 E). To directly determine 
the expression levels of Cdca7 in different hematopoietic 
subpopulations of the AGM clusters at E10.5, we obtained 
mRNA from cells sorted using specific markers for pure 
endothelial (CD31+cKitCD41CD45), hemogenic en-
dothelial (CD31+cKitCD41+CD45), prehematopoietic 
(CD31+cKit+CD41+CD45), and hematopoietic cluster cells 
(CD31+cKit+CD41+CD45+). Cdca7 was up-regulated in the 
sorted cKit+ cells, when compared with the cKit, with 5 
log2–fold difference (Fig. S2 A). The highest Cdca7 levels 
were detected in the CD31+CD41+cKit+CD45 population 
(Fig. 3 F), which contains the putative precursors of the HSCs. 
To a lesser extent, Cdca7 was also present in the population that 
contains the functional HSCs and hematopoietic progenitors 
screening, showed very poor enrichment ratios and were there-
fore considered as false positives (Fig. 1 G). Because RBPj re-
cruitment is not exclusive of genes that contain active Notch, 
we analyzed whether the truncated intracellular Notch1 (ICN1) 
was also recruited to these promoters in the AGM of E11.5 
embryos. ChIP assay using specific antibodies showed that four 
validated RBPj target promoters (Wasf1, Ect2, Cdca7, and 
hes1) also recruited active Notch1 (Fig. 1 H), supporting the 
notion that Notch1 regulates their expression at the time of 
HSC emergence.
Novel identified Notch/RBPj targets  
are Jagged/Notch-dependent genes
Because HSC generation is highly dependent on the Notch 
ligand Jag1 (Robert-Moreno et al., 2008), we focused on the 
identification of Notch/RBPj targets that are misregulated 
in a Jag1-deficient background. We obtained RNA from 
E10.5 AGMs of Jag1+/+ and Jag1/ embryos and performed 
expression analysis of our candidate genes. All selected Notch 
targets were down-regulated in the absence of Jag1, in con-
trast to the Notch ligand Dll4 which was up-regulated in this 
specific mutant (Fig. 1 I). The Notch target Gata2 was also 
down-regulated in the Jag1-deficient AGM as shown previ-
ously (Robert-Moreno et al., 2008). Conversely, transduc-
tion of AGM cells from Jag1/ embryos with active ICN1 
resulted in the up-regulation of all selected targets (from 2- to 
16-fold) compared with the control (Fig. 1 J).
Analysis of the sequence comprising 10 kb of the 5 regu-
latory regions using the Genomatix software demonstrated 
that putative RBPj-binding sites were present in the proximal 
promoter of all of the identified targets. Head-to-head dimer-
ization of the Notch factor recruited to closely localized RBPj-
binding sites (15–17 bp from core to core) is important for 
transcriptional regulation of specific genes such as Hes1 (Fig. S1; 
Arnett et al., 2010). Interestingly, we found that the Cdca7 pro-
moter contained three putative RBPj-binding sites in the 
region comprised between the 5 kb and the TSS, and it 
contained two adjacent RBPj sites separated by a distance of 
43 bp that mapped close to the TSS. This regulatory region 
was covered by the Chip-on-chip probes and was highly en-
riched in the RBPj precipitation (Fig. 2 A).
Cdca7 transcriptional activation depends on Notch signaling
We further validated the RBPj recruitment to Cdca7 using 
primers covering the different regions of the locus (Fig. 2 B). 
We confirmed that the region containing the two adjacent 
RBPj-binding sites (260 and 217 bp) was highly enriched 
in the RBPj precipitates when normalized for the control 
IgG precipitation (206-fold) or when compared with other 
regions including putative binding sites (4,087, 7,882, and 
9,004 bp) in the Cdca7 gene (Fig. 2 B). Importantly, Notch1 
and its coactivator Mam were also specifically recruited to the 
same region of the Cdca7 promoter (Fig. 2, C and D). To study 
whether Notch regulated Cdca7 transcription, we cloned the 
region comprised between 511 and 50 bp of the gene on 
a luciferase reporter vector and tested its response to Notch 
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and Fig. 3 H). To test whether CDCA7 expression during 
hematopoietic differentiation of hESC was dependent on 
Notch activity, which is known to modulate hematopoietic 
differentiation of ESCs (Yu et al., 2008; Lee et al., 2013; 
Rafii et al., 2013), we included Notch/-secretase inhibitor 
(CompE) in our experiments. We found that compE treat-
ment significantly reduced the levels of CDCA7 expression 
in both the HEP and the CD45+ populations (Fig. 3 I). Fur-
ther supporting a role for CDCA7 downstream of Notch in 
the human hematopoietic system, we found that Notch1 is 
recruited to the region spanning 400 bp to the 5 region of 
CDCA7 in human peripheral blood CD34+ cells (Lin, M.I., 
and L. Zon, personal communication).
Cdca7 maintains the undifferentiated phenotype  
of the hematopoietic lineage
To directly test the functional requirement of CDCA7 during 
mouse embryonic hematopoiesis, we obtained E10.5 AGM 
(CD31+CD41+cKit+CD45+) and maintained in the LSK 
population isolated from adult BM (Fig. 3 F). Based on all of 
this data, we proposed that CDCA7 may play a role during 
endothelial to hematopoietic transition in the human embryo 
(Ivanovs et al., 2011). We took advantage of the hemato-
endothelial differentiation system using the hESC lines H9 
and AND1 and two hematopoietic differentiation strategies: 
embryoid bodies (EBs; Fig. S2 B) and OP9 co-culture system 
(Fig. 3 G; Wang et al., 2004; Real et al., 2012; Bueno et al., 
2013). In both conditions, we observed the appearance of 
hematoendothelial precursors (HEPs; CD31+CD34+CD45), 
followed by the generation of hematopoietic cells (CD45+). 
We sorted these subpopulations, obtained mRNA, and mea-
sured the expression levels of human CDCA7 variant 2, which 
is homologous to the murine Cdca7 (Fig. S2 C). We found that 
CDCA7 mRNA was strongly enriched in the human HEPs 
obtained from both EB and OP9 differentiation systems, con-
firming the trend observed in the murine AGM cells (Fig. S2 D 
Figure . Cdca7 is a direct Notch target 
gene through two predicted RBPj-binding 
sites. (A) Schematic representation of the pro-
moter region of Cdca7 showing the array probe 
position (red circles), DNA (black dashed line), 
TSS (black arrow), putative RBPj-binding site 
(blue bars), and probe enrichment in log2 ratio 
(gray bars). RBPj-binding sites were identified 
with the STORM and Genomatix software scan-
ning from the 10- to 0-kb region of each tar-
get gene. (B) ChIP with anti-RBPj. (C) ChIP with 
anti-N1IC. (D) ChIP with anti-MAM1. In B–D, 
chromatin was extracted from E10.5 dissected 
AGMs (n = 2). (E and F) Luciferase activity from 
Cdca7 promoter (511/50 bp) WT (E) and mu-
tant RBP sites (F) in the presence of the speci-
fied transfected plasmids into HEK-293T cells 
(micrograms of transfected plasmid are indi-
cated; n = 3). In the bottom panels, Western blot 
of the transfected proteins is shown. Error bars 
represent the SD. Significant differences are 
indicated by asterisks (*, P < 0.05; **, P < 0.01).
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Figure 3. Cdca7 is expressed in mouse and human embryonic hematopoietic progenitor cells. (A) ISH of Cdca7 on E10.5 embryos.  
Arrowheads indicate hematopoietic clusters in the top panel. Fetal liver (fl) staining is shown in the bottom panel. (B) E11.5 embryo immunofluorescence 
is shown. (C) ISH comparing E10.5 Jag1+/+ with Jag1/ embryos. Dashed lines indicate the aortic endothelium and bars indicate the scale. Ao, aorta in  
the AGM region; IAHC, intraaortic hematopoietic cluster; me, mesonephros. (D–F) Cdca7 expression from the indicated purified populations from the 
embryo to the adult. (D and E) Gene expression from purified HSCs obtained from E11.5 AGM (VEC+CD45+), E12.5 FL (LSK), and LT-HSCs from adult BM 
(CD150+CD48LSK) and different subpopulations of hematopoietic progenitors and mature cells. Data are derived from public databases. (F) Cdca7 ex-
pression on purified E10.5 AGM subpopulations and adult BM LSK. (G) Experimental design of hESC hematopoietic differentiation on OP9. (H and I) HEPs 
(CD31+CD34+CD45) and CD45+ hematopoietic differentiated cells were sorted and analyzed by qRT-PCR relative to nonhematopoietic remaining cells 
(CD31CD34CD45). Cdca7 expression was determined by qPCR (n = 3). Error bars represent the SD.
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a forced differentiation into more mature CD45+cKit cells. 
Similar results were obtained from E11.5 AGM cultures 
(Fig. 4 B). Reduction in the hematopoietic progenitors was 
also detected when total cell numbers were analyzed (Fig. 4 C). 
However, total cell number after culture was similar in both 
conditions, and we did not detect any significant effect on the 
cell cycle profile or the apoptotic rate in the Cdca7-depleted 
hematopoietic cells (Fig. 4 D). These results strongly suggest 
cells and transduced them with lentiviral vectors containing 
shRNA targeting Cdca7 or the scrambled control (Fig. 4 A). 
Control cells or Cdca7 knocked down cells were cultured for 
7 d in the presence of cytokines and analyzed by flow cytom-
etry for the presence of CD45+ and cKit+ cells. In the control 
cultures, we obtained a mean of 30% of CD45+cKit+ double-
positive hematopoietic progenitors that was reduced by eight-
fold after Cdca7 knockdown. In contrast, these cultures showed 
Figure . CDCA7 is required to maintain embryonic hematopoietic progenitors. (A) shCdca7-1, shCdca7-2, and shCdca7-3 were tested in 32D 
myeloid progenitor cell line by qPCR (top) and Western blot (bottom); an unspecific band was used as a loading control. (B) E10.5 and E11.5 AGM cells 
were cultured and transduced with the same infective viral particles of shControl and shCdca7 (mix 1: shCdca7-1 + shCdca7-2; mix 2: shCdca7-1 + 
shCdca7-3). After 1 wk, the cells were analyzed by flow cytometry (CD45+cKit+: hematopoietic progenitors; CD45+cKit: differentiated hematopoietic cells). 
One representative experiment is shown. (C) Mean of three independent experiments is plotted. (D) Cell cycle profile and apoptosis was determined in cells 
after 1 wk of culture. Graphs represent mean percentage of cells in each phase (left) and percentage of cells with Annexin V staining (right) from two 
independent experiments. No statistically significant differences were found. (E) After 1 wk in the hematopoietic culture, 3,000 cells were plated in a CFC 
culture. Bars represent the mean and SD of CFCs obtained from three independent cultures. Significant differences are indicated by asterisks (*, P < 0.05; 
**, P < 0.01; ***, P < 0.001).
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that CDCA7 regulates hematopoietic emergence and differ-
entiation rather than survival or proliferation of existing he-
matopoietic cells. Furthermore, knocking down Cdca7 in 
AGM cells totally abolished (in E10.5 cells) or strongly reduced 
(in E11.5 cells) their capacity to generate lineage-specific co-
lonic (CFCs; Fig. 4 E). These results indicate that CDCA7 
has a dominant role in maintaining the undifferentiated phe-
notype of the newly formed HSCs and progenitors.
Cdca7 is required for in vivo definitive  
hematopoietic development in zebrafish
We first confirmed the expression pattern of cdca7 in the 
zebrafish embryos by ISH and found expression in the aorta of 
94.3% of WT embryos (DMSO-treated control), whereas 
in vivo treatment with the Notch/-secretase inhibitor DAPT 
led to a severe reduction of cdca7 levels in 63% of treated em-
bryos (n = 2, 33/35 DMSO vs. 10/27 DAPT showing nor-
mal cdca7 levels; Fig. 5 A; Thisse et al., 2001). These results 
indicate that cdca7 expression is also downstream of Notch in 
this system.
Next, we tested the requirement of cdca7 during the HSC 
generation process in zebrafish. We took advantage of anti-
sense cdca7 morpholino oligos (MOs) that had been previ-
ously tested (Ma et al., 2012; 2.3-fold reduction detected by 
qRT-PCR [not depicted]). By ISH, we detected cmyb ex-
pression (specifically labeling definitive HSCs and progenitors) 
in 84.4% of WT embryos compared with 41.9% of the em-
bryos injected with cdca7 MOs (n = 3, 77 control embryos 
and 62 morphants analyzed; Fig. 5, B and G). Similar results 
were obtained with a second ATG MO against cdca7 (57.1% 
of treated embryos showed cmyb expression; not depicted). 
Moreover, the reduction in runx1 expression as detected by 
ISH indicated that cdca7 was required for specification of he-
mogenic endothelium (7/14 untreated embryos showed runx1 
expression compared with 1/8 in the cdca7 MO-injected ones 
[not depicted]). Similarly, cdca7 MO treatment led to a reduc-
tion in the number of GFP-positive hematopoietic cells in 
the CD41-GFP line (Lin et al., 2005; 33.7 ± 3.6 in the un-
treated compared with 19.9 ± 3.0 cells in the MO-treated, 
P = 0.009; n = 1, 13, and 14 embryos, respectively; Fig. 5 C). 
The fact that CD41-GFP marks both HSCs and erythroid/
myeloid progenitors (EMPs), with EMPs being independent 
of Notch signaling (Bertrand et al., 2010), is in agreement 
with the observation that the number of CD41-GFP–positive 
cells was only reduced by 33% in the MO-treated embryos. 
EMPs have a posterior blood island/venous origin (Lawson 
and Weinstein, 2002), whereas HSCs have an arterial AGM 
origin (Warga et al., 2009). Consequently, detection of Flt1-
RFP, which is exclusively expressed in arterial cells (Bussmann 
Figure 5. HSC formation is impaired in cdca7 morphants. (A) cdca7 
ISH of representative embryos treated at 6 hpf for 24 h with DMSO or  
100 µM DAPT. (B) Representative embryos (top) and detailed images of AGM 
region (bottom) from embryos treated with control or cdca7 MOs. Hema-
topoietic cells were detected by cmyb ISH at 30 hpf or by CD41-GFP at  
50 hpf (C). The number of CD41-GFP–positive cells is significantly reduced 
upon cdca7 MO injection (P = 0.01). (D) Representative images from 
CD41-GFP and Flt1-RFP embryos treated with control or cdca7 MOs. 
Number of double-positive cells is indicated. A detail of CD41-GFP+/Flt1-RFP+  
HSCs is depicted in the inset. (E and F) The dorsal aorta integrity is  
revealed by gridlock (hey2) and EphrinB2a expression in both WT and 
cdca7 MO-injected embryos. The numbers in the panels indicate the num-
ber of embryos of the total pool that displayed phenotype or the number 
of positive cells. (G) The percentages of cmyb expression are indicated in 
the graph. Bars: (A, B, E, and F) 200 µm; (C and D) 100 µm.
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of hematopoietic progenitor/stem cells. In agreement with this 
possibility, we found that down-regulation of Cdca7 in AGM 
cells results in forced differentiation of the cKit+ progenitor 
population. In the ESC differentiation system, CDCA7 is 
temporarily activated in the CD34+CD45 HEPs but reduced 
in the CD45+ population, which could partially contribute to 
the engraftment inability of ESC-derived hematopoietic cells.
Cdca7 was previously identified as a downstream target of 
Myc and E2F transcription factors (Haggerty et al., 2003; 
Goto et al., 2006). CDCA7 can also interact with Myc in the 
nucleus and participate in Myc-dependent transformation 
events. It is proposed that CDCA7 participates in cell cycle 
progression, which may be relevant for its involvement in 
oncogenic processes (Whitfield et al., 2002). In this sense, 
CDCA7 is overexpressed in a variety of hematological tu-
mors, predominantly in chronic myelogenous leukemia, but 
it has limited cell-transforming capacity both in vivo and 
in vitro (Osthus et al., 2005). However, we have not found any 
effect of CDCA7 on proliferation, nor cell death, in AGM 
hematopoietic cultures or in zebrafish hematopoietic cells 
(unpublished data). The precise physiological and biochemi-
cal function of CDCA7 remains obscure and requires further 
investigation. Here we show that Cdca7 is expressed in differ-
ent HSC and progenitor subpopulations, including the LT-
HSCs, and it is important for maintaining the undifferentiated 
phenotype. Moreover, our study shows that Cdca7 is down-
stream of Notch in hematopoietic cells in zebrafish, mouse, 
and human, indicating the high conservation of the Notch/
RBPj/CDCA7 axis in hematopoietic development (Ciau-
Uitz et al., 2014). Interestingly, Cdca7 expression was also 
enriched in the lgr5+ intestinal stem cells (van der Flier et al., 
2009), suggesting a more general stemness-related function.
MATERIALS AND METHODS
Animals. CD1, C57B6/J WT, and Jagged1/ (Xue et al., 1999) strains were 
used. Animals were housed under pathogen-free conditions, and all proce-
dures were approved by the Animal Care Committee of Parc de Recerca 
Biomèdica de Barcelona and Generalitat de Catalunya. Embryos were obtained 
from timed pregnant females and staged by somite counting: E10.5 (31–40 sp), 
E11.5 (43–48). The detection of the vaginal plug was designated as day 0.5. 
Mice and embryos were genotyped by PCR.
qRT-PCR. Total RNA was extracted with a QIAGEN kit, and the RT-
First Strand cDNA Synthesis kit (GE Healthcare) was used to produce cDNA. 
qRT-PCR was performed in the LightCycler480 system using SYBR Green I 
Master kit (Roche). Primers used are shown in Tables S2 and S3.
Promoter analysis and luciferase assays. Cdca7 promoter was analyzed 
using Genomatix software. For luciferase assays, Cdca7 was generated cloning 
the region from 511 to 50 bp of Cdca7 TSS into the pGL3 vector (primers: 
forward, 5-TGCTAGATAAGAGGTGCTATGCTC-3; and reverse, 
5-GTGCTAGCACCCACCAACC-3) and verified by sequencing. Two 
nucleotide (CC>AA) mutations were introduced by PCR at the 260 site 
alone or at both 260 and 217 core sites in the Cdca7 reporter. Luciferase 
reporter assays were performed in HEK-293T cells. Cells were seeded in 
12-well plates at 5 × 104 cells/well. Cdca7p reporter, ICN1, Mam, dn-RBPj, 
or irrelevant DNA and CMV–-Galactosidase plasmids were transfected in 
triplicate. Cells were transfected using polyethylenimine (Polysciences, Inc.). 
To reduce endogenous ICN1 levels, HEK-293T cells were treated with 
-secretase inhibitor DAPT (EMD Millipore) at 50 µM final concentration. 
et al., 2010), together with CD41 can distinguish between 
EMPs and HSCs (because RFP is very stable and HSCs re-
main RFP positive in the caudal hematopoietic tissue [CHT; 
Bertrand et al., 2008]). Quantification of the number of HSCs 
(CD41-GFP+/Flt1-RFP+) in the CHT demonstrated that 
control embryos contain 21.2 ± 3.3 GFP+/RFP+ compared 
with 7.4 ± 3.1 cells in the cdca7 MO-injected embryos (data 
from one experiment; six and nine embryos analyzed, respec-
tively; P = 0.01; Fig. 5 D). Supporting the notion that cdca7 
knockdown does not affect arterial development, we did not 
detect any significant alteration in the expression levels of the 
arterial genes gridlock and EphrinB2a by ISH and expression of 
Tg(Flt1-RFP) in our MO-treated embryos (Fig. 5, D–F). To-
gether, our results demonstrate that CDCA7 is downstream 
of Notch/RBPj and contributes to the emergence of HSCs 
and maintenance of hematopoietic progenitors during em-
bryonic development.
DISCUSSION
Our genome-wide analysis of RBPj-targeted genes during 
embryonic hematopoietic development provides a source of 
candidates to function as Notch mediators during HSC speci-
fication. Because it is still under debate which is the embryonic 
population of cells that requires Notch activity to give rise to 
HSCs, we have used pools of dissected AGMs from E11.5 em-
bryos to search for RBPj-binding promoters. To further define 
the best candidate genes for Notch-dependent regulation in 
the AGM, we have focused on those that contain conserved 
adjacent RBPj-binding sites (Arnett et al., 2010) and showed 
Notch1 recruitment in their promoters. Furthermore, because 
Jag1-deficient embryos display specific hematopoietic defects 
(Robert-Moreno et al., 2008), we have selected genes whose 
expression depends on Jag1 in the AGM. In this work, we 
have focused on the Cdca7 gene, which scored positive to all 
of the aforementioned criteria, as a new Notch target gene in-
volved in early hematopoietic development. In fact, we found 
that CDCA7 is required for the HSC and hematopoietic pro-
genitor emergence in the zebrafish embryo.
Understanding the cellular and molecular mechanisms in-
volved in HSC development is crucial for multiple therapeutic 
applications such as generation of HSCs from ESCs or in-
duced pluripotent stem cells. This includes deciphering how 
endothelial-like cells acquire the hematopoietic fate and how 
a very restricted population achieves the stemness character-
istics (LT-HSC; Taoudi et al., 2008) instead of just going 
through the hematopoietic pathway. We and others have pre-
viously shown that extra-embryonic yolk sac and embryonic 
stem–derived hematopoiesis do not require Notch activity 
(Schroeder et al., 2003; Robert-Moreno et al., 2007; Real et al., 
2012), whereas it is essential to obtain transplantable defini-
tive HSCs (Kumano et al., 2003). Here we found that Cdca7 
is induced in a Notch-dependent manner during the initial 
stages of ESC differentiation into the hematopoietic lineage, 
but its expression is not maintained in the CD45+ mature 
population. Our results strongly suggest that sustained Notch 
signal and Cdca7 expression contribute to prevent maturation 
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and 0.1 µg/ml flt3. Cells were infected with the same amount of infective par-
ticles (shControl or shCdca7), and puromycin was added the following day. 
After 1 wk, cells were analyzed by FACS, and 3,000 cells from each condi-
tion were plated in duplicates in M-3434 semisolid medium (STEMCELL 
Technologies) to perform a CFC assay. After 7 d, the presence of hemato-
poietic colonies was scored under the microscope.
Flow cytometry analysis and sorting. The AGM region was dissected 
from E10.5 embryos and dissociated in 0.12% collagenase (Sigma-Aldrich) in 
PBS supplemented with 10% FBS for 20 min at 37°C. The cells were ana-
lyzed by flow cytometry in a FACS Fortessa (BD). FlowJo software was used 
to analyze the results. Dead cells were excluded by DAPI. The antibodies 
CD31-PE, CD45-PECy7, and CD117-APC were purchased from BD. After 
staining for CD45, cells were fixed (Invitrogen) for cell cycle analysis, washed 
with PBS and 10% FBS, and stained with anti–Ki67-APC (BD) in permea-
bilizing buffer (Invitrogen) for 20 min at room temperature. Then, cells were 
resuspened in PBS containing 2 µg/ml DAPI (Invitrogen). Annexin V stain-
ing was performed as indicated by the apoptosis detection kit (eBioscience), 
and cells were analyzed in binding buffer containing 5 µg/ml DAPI (Invit-
rogen). Cells were analyzed by flow cytometry.
ISH and immunofluorescence. For ISH, precisely timed embryos were 
fixed overnight at 4°C in 4% paraformaldehyde and subsequently embedded 
in OCT (Tissue-Tek). Embryos were sectioned in a Leica RM2135 cryostat 
at 16 µm. Digoxigenin (DIG)-labeled probes were generated from a pGEMT 
easy plasmid (Promega) containing Cdca7 cDNA (75/1,220). 1.1 kb of Cdca7 
transcript was cloned using the following: forward, 5-AAAGAATTCGAG-
GCTCGCCGCGCGC-3; and reverse, 5-AAACTCGAGCTACGCTTG-
CATTTCAAATTC-3. Images were acquired with an Olympus BX-60. For 
immunostaining, embryos at E10.5 and E11.5 were fixed overnight at 4°C in 
37% formaldehyde and subsequently dehydrated with ethanol and embedded 
in paraffin. Anti-CDCA7 antibody was developed by AVIVA (ARP66756). 
Images were acquired in confocal microscope (Leica SP5). Representative 
images were edited on Adobe Photoshop CS4 software.
hESC hematopoietic cell differentiation and cell sorting. hESC-OP9 
co-cultures were performed as previously described (Vodyanik and Slukvin, 
2007) with some modifications (Real et al., 2012). In brief, OP9 stroma was 
prepared in gelatin-coated 10-cm dishes in -MEM basal medium supple-
mented with 20% nonheat-inactivated FBS. The hESC lines AND1 and H9 
grown in Matrigel-coated flasks were prepared as a suspension of small ag-
gregates using Collagenase IV treatment followed by gentle scraping in dif-
ferentiation medium (DM; -MEM basal medium, 10% nonheat-inactivated 
FBS, 100 mM monothioglycerol, and 50 mg/ml ascorbic acid) and plated on 
top of the 8-d OP9 stroma in 10 ml DM. The next day, media were replaced 
by 20 ml DM to remove unattached cells; where indicated, we added 200 nM 
Compound E (CompE; EMD Millipore) to block Notch activation. From 
day 3 of co-culture, a half-volume media change was performed every other 
day. At days 8 (for HEP purification) and 15 of co-culture (for CD45+ puri-
fication), cells were treated for 1 h with collagenase IV, followed by 20 min 
with Tryple (Gibco). Single cell suspensions were stained with anti–mouse 
CD29-FITC, anti–human CD31-PE, CD34-PE-Cy7, and CD45-APC an-
tibodies, and human HEPs and CD45+ cells were purified by cell sorting as 
described above within the CD29 human population.
To allow hEB formation, undifferentiated hESCs were treated with col-
lagenase IV and scraped off the Matrigel. These hESC clumps were trans-
ferred to low-attachment plates (Corning) and incubated overnight in DM 
(KO-DMEM), 20% nonheat-inactivated FBS, 1% nonessential amino acids, 
1 mmol/l l-glutamine, and 0.1 mmol/l -mercaptoethanol. From day 1 the 
media was changed every 3 d to the same DM supplemented with hemato-
poietic cytokines: 300 ng/ml SCF, 300 ng/ml Flt3L, 10 ng/ml IL-3, 10 ng/ml 
IL-6, 50 ng/ml G-CSF, and 25 ng/ml bone morphogenetic protein 4 (BMP-4; 
Ramos-Mejia et al., 2012). At day 15 of differentiation, hEBs were dissoci-
ated using collagenase B (Roche) for 2 h at 37°C, followed by 10-min in-
cubation at 37°C with enzyme-free cell dissociation buffer (Invitrogen). 
Luciferase was measured 72 h after transfection according to the manufactur-
er’s instructions (Luciferase Assay System; Promega). Expression levels of 
transfected proteins were verified by Western blot.
ChIP assay and ChIP-on-chip. Chromatin was obtained from a pool of 
40 dissected AGMs at E11.5. ChIP was performed as previously described 
(Aguilera et al., 2004) with minor modifications. In brief, cross-linked chro-
matin from E10.5 or E11.5 dissected AGMs was sonicated for 10 min, me-
dium power, 0.5 interval with a Bioruptor (Diagenode) and precipitated 
with anti-RBPj (Chu and Bresnick, 2004), anti-ICN1 (Abcam), and anti-
Mam (Santa Cruz Biotechnology, Inc.). After cross-linkage reversal, DNA 
was used as a template for PCR or for array hybridization. Mouse promoter 
ChIP-on-chip microarray SET (Agilent Technologies) was used to identify 
RBPj targets. It covers 70,000 best identified gene regions with a 5.5- to 
2.5-kb range and has, on average, 25 probes per gene with a mean probe to 
probe distance of 200 bp. The ChIP-on-chip was performed with dye swaps 
and one IgG control was brought along. Enrichment analysis was done by 
comparing the precipitation normalized dye swap signal with input control 
signal. Alternatively, qPCR was performed with SYBR Green I Master 
(Roche) in the LightCycler480 system. Primers used are in Table S4.
ChIP-on-chip analysis. For calling the enriched peaks we used two inde-
pendent algorithms, namely Chipper91 and Bioconductor92 package (ver-
sion 2.7) iChIP (both iChIP1 and iChIP2; version 1.4.0). In the latter, 
background was corrected and Loess normalized data were used as input. For 
this purpose, the Bioconductor package Limma 93 was used. Multiple test-
corrected (false discovery rate [FDR]; cutoff 0.05 for Chipper and 0.01 for 
iChIP) enriched probes were annotated to Ensembl (version 60) genes94. 
The RBPj target genes identified by both Chipper and iChIP were put in a 
highly confident RBPj targets dataset. Of this dataset, the region 5 to 5 kb 
from the TSS was scanned using the STORM program (version 9.4; 95) and 
Transfac RBPj position frequency matrix96 (using V$RBPJK_01, M01112) 
for putative in silico RBPj binding site determination. GO (Ashburner et al., 
2000) functional and pathway (KEGG) enrichment analysis of genes was 
done by using GiTools97. Functional annotation of differentially target 
genes is based on GO (Ashburner et al., 2000), as extracted from Ensembl 
(Hubbard et al., 2007) and KEGG pathway databases (Kanehisa et al., 2008). 
Accordingly, all genes are classified into the ontology categories biological 
process (GOBP) and pathways when possible. We have taken only the GO/
pathway categories that have at least 10 genes annotated. We used Gitools 
for enrichment analysis and heat map generation (Perez-Llamas and Lopez-
Bigas, 2011). Resulting p-values were adjusted for multiple testing using the 
Benjamini and Hochberg method of FDR (Benjamini et al., 2001). All data 
have been deposited in the GEO database (accession no. GSE52094; included 
in Table S1).
Cell culture, viral particle production, and viral infection. 32D cells 
were cultured in Iscove’s and 10% FBS supplemented with 10% WeHi- 
IL3–conditioned media. Hematopoietic cells from disrupted AGMs were 
incubated in Iscove’s, 10% FBS, and 10% IL3– and 10% stem cell factor 
(SCF)–conditioned medium plus 0.2 µg/ml IL6 and 0.1 µg/ml flt3. Recom-
binant lentiviruses were produced by transient transfection of HEK-293T. In 
brief, subconfluent HEK-293T were cotransfected with 20 µg of transfer 
vector, 15 µg of packaging plasmid (psPAX2), and 6 µg of envelope plasmid 
(pMD2.G). After 3 d, supernatant was ultracentrifuged in a Beckman Coul-
ter L-70 at 26,000 rpm for 2 h at 4°C and viral pellet resuspended in 100 ml 
PBS. Viruses were titrated in the 32D cell line, and the same amount of virus 
was used to infect the different conditions. Cultures were maintained for up 
to 12 d. Cells were harvested by pipetting and examined for hematopoietic 
development by flow cytometry.
Hematopoietic colony assay (CFC). The dissected AGMs were digested 
in 0.12% collagenase (Sigma-Aldrich) in PBS supplemented with 10% FBS 
for 20 min at 37°C. AGM disrupted cells were cultured 7 d in Iscove’s, 10% 
FBS, and 10% IL3– and 10% SCF–conditioned medium plus 0.2 µg/ml IL6 
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The dissociated cells were stained as indicated above. Work with hESCs has 
been approved by the “Comisión Nacional de Control y Garantías” del In-
stituto de Salud Carlos III.
Zebrafish maintenance, morpholinos, microinjection and ISH. Em-
bryos and adult fish were raised and maintained under standard laboratory 
conditions in the Erasmus Animal Facility (EDC). For the cdca7 probe, cdca7 
full length was cloned from cDNA using the primers forward, 5-TATTAT-
GAATTCATGAACCTGCGGAGCTAC-3; and reverse, 5-TATTATT-
CTAGATTATTCACTTTCCTCCAG-3. Subsequently, the cdca7 antisense 
probe was made using 500 bp at the 3 end of the gene using a digest of the 
natural Bgl1 restriction site in cdca7. DAPT treatment was performed ac-
cording to Geling et al. (2002). Dechorionated embryos were treated at 6 h 
postfertilization (hpf) for 24 h in E3 containing either DMSO or DAPT. 
A 10-mM stock (in DMSO) was diluted in E3 medium to a final concentra-
tion of 100 µM. Embryos were fixed in 4% paraformaldehyde containing 
sucrose for ISH.
An antisense splice blocking MO against cdca7 (3-TACTGTAGATA-
CAAACCATTTCTGT-5), an ATG blocking MO against cdca7 (3-AGC-
TCCTGTAGCTCCGCAGGTTCAT-5), and p53 have been previously 
described (Ma et al., 2012) and were purchased from Gene Tools. MOs 
(4 ng) were injected alone or in combination with p53 MO into one-cell-
stage zebrafish embryos. MO knockdown was tested using the following 
primer sets: cdca7 forward, 3-CAGACGAGAAGCTCCACTCA-5; cdca7 
reverse, 3-TAGGCTCAGGCTTCACTGGT-5; elfa qRT-PCR control: 
elfa forward, 3-CTTCTCAGGCTGACTGTGC-5; and elfa reverse, 3-
CCGCTAGCATTACCCTCC-5. WISH for zebrafish embryos was per-
formed at 30 hpf as described previously (Patterson et al., 2005). The 
CD41-GFP and CD41-GFP/Flt1-RFP imaging was performed at 50 hpf 
and the area imaged was the CHT. cmyb, gridlock (grl), and ephrinB2a probes 
(Thompson et al., 1998) and CD41-GFP (Lin et al., 2005) were used as 
markers for HSCs in zebrafish. Flt1-RFP was used as a marker for arterial 
cells (Bussmann et al., 2010). CD41-GFP and Flt1-RFP transgenic zebrafish 
were kept in a homozygous state. Significance was determined by the Stu-
dent’s t test.
Online supplemental material. Fig. S1 shows that Hes1 predicted RBPj-
binding sites. Fig. S2 shows Cdca7 is expressed in human and mouse hemato-
poietic progenitors. Table S1, included as a separate PDF file, shows Chipper- and 
iChip-identified RBPj target genes. Tables S2 and S3 show mouse and 
human expression RT-PCR primers, respectively. Table S4 shows pro-
moter mouse primers. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20131857/DC1.
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